İrem UZUN -TDO- UK regulators have approved the use of the Oxford University-AstraZeneca coronavirus vaccine, which is cheaper and easier to distribute than some rivals and could in time offer a route out of the pandemic for large parts of the world. The UK government said it would follow a new immunization strategy for the vaccine, which will prioritize giving the first in a series of two vaccine doses to as many people as possible, before administering a second dose up to 12 weeks later. This will apply to both the newly approved Oxford-AstraZeneca vaccine and the Pfizer-BioNTech vaccine which is already being administered.
Priority groups for immunization have already been identified, starting with care home residents, the over-80s, and health and care workers. It comes as millions more in England are placed in tier four restrictions. The UK has ordered 100 million doses of the new vaccine- enough to vaccinate 50 million people. Eventually all over 50s and younger adults with health conditions will be offered a jab in the first phase of the rollout- more than 25 million people in total. It is hoped that about two million patients a week could soon be vaccinated with two vaccines now approved.